Tonix Pharma (TNXP) Misses Q2 EPS by 1405c
Tweet
Share
E-mailGet Alerts TNXP Hot Sheet
Join SI Premium – FREE
Tonix Pharma (NASDAQ: TNXP) reported Q2 EPS of ($19.28), $14.05 worse than the analyst estimate of ($5.23). Revenue for the quarter came in at $2.21 million versus the consensus estimate of $3.5 million.
For earnings history and earnings-related data on Tonix Pharma (TNXP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SpaceX signs compute deal with Reflection - CNBC
- Alphabet (GOOGL) falls over 5%
- Popular stocks with increasing option volume: SPCX INTC AVGO AMC MU PLTR NYT
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
